Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday’s Mid-Day Session
Gainers
HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.
Analyst Says Affimed’s ‘Innate Cell Engagers Like No Others,’ Sees Mammoth Upside
H.C. Wainwright initiated coverage on Affimed NV (NASDAQ: AFMD), a clinical-stage biotechnology company focused on developing innate cell engagers (ICEs) for cancer treatment.
Crude Oil Rises Sharply; Adicet Bio Shares Plunge
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 250 points on Monday
Affimed Presents Updated Data For AFM28 Demonstrating Efficient Elimination Of Leukemic Stem And Progenitor Cells In Combination With Allogeneic NK Cells In Preclinical Models Of Acute Myeloid Leukemia And Myelodysplastic Syndrome At The ASH 2022 Meeti…
AFM28 efficiently directs allogeneic NK cells to CD123-positive leukemic cells, including leukemic stem and progenitor cells, inducing their depletion in samples of patients with Acute Myeloid Leukemia (AML) and
Benzinga’s Top Ratings Upgrades, Downgrades For December 12, 2022
Upgrades For Colliers International Group Inc (NASDAQ:CIGI), Goldman Sachs upgraded the previous rating of Neutral to Buy. Colliers…
4 Analysts Have This to Say About Affimed
Analysts have provided the following ratings for Affimed (NASDAQ:AFMD) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…